UK-based CDMO Upperton Pharma Solutions has launched a nasal delivery development platform called UpperNose, the company said. The UpperNose services include pre-formulation analyses, dosage form selection, and formulation and process development through to clinical trial manufacturing. Upperton Chief Scientific Officer Richard Johnson said, "The delivery of … [Read more...] about Upperton Pharma Solutions launches nasal delivery development platform
Products and Services
Lonza joins IPAC-RS
CDMO Lonza has joined the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS), the company said. In the announcement of its IPAC-RS membership, Lonza specifically noted its planned participation in discussions related to particle engineering, inhaler testing, devices, and packaging. In July 2020, Lonza announced that it had … [Read more...] about Lonza joins IPAC-RS
Koura opens HFA 152a production facility
Koura has officially opened a new facility for the production of HFA 152a in Runcorn, UK, the company announced. According to Koura, the propellant produced at the facility, which will be marketed as "Zephex 152a," will be available at commercial scale within a few months. In December 2019, Italian pharma company Chiesi said that it had signed an agreement with … [Read more...] about Koura opens HFA 152a production facility
Proveris Scientific launches Kinaero Cx collection system for automated MDI testing
Proveris Scientific has announced the launch of a new collection system called Kinaero Cx that is designed for improved sample collection consistency during MDI testing. The new system, which includes the company's Vereo automated actuator technology, controls parameters for inhaler shaking and actuation, shake-to-fire timing, and flow rate and can be used for both … [Read more...] about Proveris Scientific launches Kinaero Cx collection system for automated MDI testing
DFE Pharma, Sterling, and Harro Höfliger partner as “INTO” to offer DPI development services
Inhaled lactose manufacturer DFE Pharma, API manufacturer Sterling, and filling/packaging company Harro Höfliger have partnered to create an early development service for DPIs called "INTO" (Inhalation Together). According to the INTO web site, the partnership will offer API development and characterization services, pre-formulation and formulation studies, and … [Read more...] about DFE Pharma, Sterling, and Harro Höfliger partner as “INTO” to offer DPI development services
Sandoz acquires inhaler developer Coalesce Product Development
Declaring that it is "determined to grow its portfolio in the complex generics space," Novartis generics division Sandoz announced its acquisition of device device developer Coalesce Product Development. Coalesce's inhaler technology include MDI, breath-actuated MDI, and DPI platforms. Sandoz said that it "sees respiratory as a key pillar of its ambitious long-term … [Read more...] about Sandoz acquires inhaler developer Coalesce Product Development
Adherium submits 510(k) for Hailie sensor to be used with Ellipta DPIs
Inhaler monitoring company Adherium has announced the submission of a 510(k) for a new Hailie sensor designed specifically for use with Ellipta DPIs. In September 2021, the FDA cleared another version of the next generation Hailie sensor for use with Symbicort MDIs. The sensors, which snap on to the outside of the device, connect to a cloud-based monitoring platform … [Read more...] about Adherium submits 510(k) for Hailie sensor to be used with Ellipta DPIs
HCmed, Formosa Laboratories, and Formosa Pharmaceuticals partner on new inhalation CDMO
Device maker HCmed Innovations has partnered with Formosa Laboratories and Formosa Pharmaceuticals to offer contract development and manufacturing services for inhaled drugs, HCmed announced. Formosa Laboratories already offers CDMO services for pharmaceutical products; the new services will also incorporate Formosa Pharmaceutical's nanotechnology platform and HCmed's … [Read more...] about HCmed, Formosa Laboratories, and Formosa Pharmaceuticals partner on new inhalation CDMO
Broughton launches US subsidiary
Broughton, a CRO that offers development and analysis of inhaled drugs, especially nicotine and cannabinoid products, has announced the establishment of a US subsidiary. Tony Jones, who has most recently been Senior Managing Health Scientist at consulting firm Cardno Chemrisk, was named Managing Consultant of the new business. Jones commented, "I am delighted to be … [Read more...] about Broughton launches US subsidiary
TFF Pharmaceuticals partners with Catalent for DPI development and manufacturing
TFF Pharmaceuticals has partnered with CDMO Catalent for scale-up and manufacturing of dry powder formulations based on TFF's thin film freezing technology the companies have announced. The partnership will make the TFF technology available to other Catalent clients as well. Catalent notes that the TFF technology is its second addition to its inhaled dry powder … [Read more...] about TFF Pharmaceuticals partners with Catalent for DPI development and manufacturing